Mitochon Pharmaceuticals

Private

Blue Bell, PennsylvaniaHealthcare & Life Scienceshttps://www.mitochonpharma.com/

Last Round

Grant

May 10, 2022

Total Funding Raised

$2.28M

Company Overview

Mitochon Pharmaceuticals is a biotechnology company that develops drugs targeting the mitochondria to treat a host of serious diseases with significant unmet medical needs, including neurodegenerative and neuromuscular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

mitochondrial modulatordisease modifying therapyneurodegenerative disease treatmentneuroprotectionclinical stage biotechsmall molecule therapychemical uncouplingALS treatmentorphan drugfasting mimeticneuromuscular disease treatmentHuntington's disease treatmentmultiple sclerosis treatmentAlzheimer's disease treatmentParkinson's disease treatmentdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mitochon Pharmaceuticals Comparables

Compare Mitochon Pharmaceuticals with similar companies based on industry and business-model similarity.

Mitochon Pharmaceuticals comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Mitochon Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	May 10, 2022
Grant	Sep 28, 2021
Grant	Oct 3, 2017
Seed	May 17, 2016

View all Funding Rounds

Mitochon Pharmaceuticals Investors

Notable investors and investment history

Mitochon Pharmaceuticals investors
Investor	Rounds
Benjamin Franklin Technology Partners	Seed
Emily's Entourage	Grant
Cures Within Reach	Seed
BrightFocus Foundation	Grant
The Michael J. Fox Foundation for Parkinson's Research	Grant
Medical Technology Enterprise Consortium	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 21, 2026
Monthly visitors grew 58% MoM, from 1.2K to 2K.
May 3, 2025
Monthly visitors increased 143% MoM.

View all signals

Mitochon Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Mitochon Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mitochon Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersBlue Bell, Pennsylvania

Employee Range4

Year Founded2014

Last FundingMay 10, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.